Effect of the Combination of Trabectedin and Pegylated Liposomal Doxorubicin in a BRCA2 Mutation Carrier with Recurrent Platinum-Sensitive Ovarian Cancer
Introduction: The current standard of care for ovarian cancer is optimal cytoreduction with adjuvant chemotherapy based on a platinum/taxane combination. Although the response rate to this therapy is high, most patients ultimately relapse. Response to second-line therapy and prognosis are linked to...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Karger Publishers
2017-05-01
|
| coleção: | Case Reports in Oncology |
| Assuntos: | |
| Acesso em linha: | http://www.karger.com/Article/FullText/475707 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|